Autism Diagnostics Lab Launches First Commercial Urine-Based Microbial-Derived Metabolite Gut & Brain Health Test For Autism Screening In The U.S.

Autism Diagnostics Lab, a precision diagnostics company, launched the MDM Gut & Brain Health Test in the United States, a urine-based screening tool for autism. The test is available for children ages 2 and older through the company's Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory network.

The MDM test measures a panel of microbially derived metabolites (MDMs), which published research identified as biomarkers associated with autism-related gut-brain and metabolic signatures. In that study, published in Molecular Psychiatry, the panel demonstrated 90% sensitivity and 100% specificity in distinguishing children with autism from typically developing controls. The test . . .